Hepatitis B Interactive

About Hepatitis B Interactive

This update has improved dynamic features of the hepatitis B interactive app based on feedbacks and emails from several colleagues and patients globally. I have included a section where those being monitored can cross check the tests they need to perform and cross check their treatment status. Redundant images have been removed in order to provide room for the public to interact with the features of the app for maximal benefits.

Some dormant aspects of the app were removed in order to reduce clutter and allow access to more useful products. The links to treatment of hepatitis B guidelines under "symptoms, signs and management of hepatitis B" is now responsive and can lead you to an actual page to access the most upto date guidelines for management of HBV.

Hepatitis B, one of the liver conditions that affects approximately 400 million people worldwide is a potent carcinogen. In some countries, 1 in 5 persons have hepatitis B, and most of these acquired the virus in childhood or perinatally. The latter portends the fact that chronicity if imminent, providing longterm complications such as end stage cirrhosis and primary liver cancer.

The update here contains CME activity that issues a certificate for your CME (as evidence for CPDs), often required for revalidation services.

Indeed, publications in Western countries confirm the fact that whereas deaths from cardiorespiratory and other diseases have realised a significant decline, that from liver diseases have been on the rise; and that, exponentially. We intend to mitigate this menace by raising awareness and supporting those that may have hepatitis B and or at risk of infection.

Within this app, we will discuss scenarios such as 1. implications of a diagnosis of hepatitis, 2. How to participate in supporting you to remain healthy, 3. How to recognise when you are due to commence treatment etc. 4. Summary of risk factors for hepatitis B, 5. Score system to compare against your results for pre-qualification for treatment, 6. Risk factors, 7. Signs, symptoms and management of hepatitis B, and more.

Worthy works Ltd is our registered name. We are a group of doctors with expertise in various fields of medicine, interested to promote health of the population as well as prevent suffering for many.

I am a gastroenterologist with academic research interest in liver diseases, there is a bit of heavy lineage towards advice to those having issues with liver conditions. I have been involved in international projects towards supporting and treating patients with chronic hepatitis B infection. I am a member of PROLIFICA - a consortium that administered an EU funded liver fibrosis and cancer prevention programme in West Africa. My PhD work had discovered candidate urinary biomarkers of hepatocellular cancer in mostly, hepatitis B infected patients.

Current version is just an update in the icon to meet the requirement of google.